17. SUBSEQUENT EVENTS‌

There have been no subsequent events that occurred during the period subsequent to the date of these condensed consolidated financial statements that would require adjustment to our disclosure in the condensed consolidated financial statements as presented, except as described below:

2023 Convertible Note

Pursuant to the 2023 Purchase Agreement and Note, on October 5, 2023, the Company and the Holder entered into the first amendment to 2023 Note which amends the 2023 Note and lowers the floor price for conversion of the note from $2.70 to $0.40.

During October 2023, the Company issued 1,330,634 shares of its common stock with a value at issuance of $2,614,925 upon the conversion of principal, interest and derivative liability in the aggregate amount of $3,706,682. The $1,091,777 excess of the aggregate amount of liabilities converted over the value of the shares issued represents the liability for a cash true up payment owed to the holder.

Equity Line of Credit

October 5, 2023, the Company requested a drawdown on the New ELOC and issued an aggregate of 39,000 shares of the Company’s common stock for gross proceeds of $76,449, less placement agent fees of $6,116.